RMED Stock Statics Stock Price History Balance Sheet
Ra Medical Systems was founded in 2002 to design, develop, and commercialize excimer lasers as tools for the treatment of vascular and dermatological diseases .
Pharos excimer laser system was launched in October 2004 and was used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma.
The company sold these dermatological products and services in August 2021 to focus solely on the larger vascular business opportunity.
In May 2017, the DABRA laser and single-use catheter (together “DABRA”) received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease and has an intended use for ablating a channel in occlusive peripheral vascular disease.
DABRA is our minimally-invasive excimer laser and single-use catheter system that is used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease, or PAD, both above- and below-the-knee.
Historical Stats and Price Data Currency in USD
Date Open High Low Close* Adj Close** Volume Mar 25, 2022 0.4200 0.4299 0.3900 0.4048 0.4048 3,272,229 Mar 25, 2022 0.4200 0.4300 0.3900 0.4000 0.4000 3,333,600 Mar 24, 2022 0.4300 0.4600 0.4200 0.4400 0.4400 6,456,300 Mar 23, 2022 0.5200 0.5300 0.4900 0.5100 0.5100 4,913,200 Mar 22, 2022 0.5400 0.5400 0.4600 0.5100 0.5100 5,758,000 Mar 21, 2022 0.5000 0.5800 0.4900 0.5200 0.5200 7,790,000 Mar 18, 2022 0.4600 0.5000 0.4500 0.4700 0.4700 3,799,400 Mar 17, 2022 0.4300 0.4800 0.4200 0.4600 0.4600 4,358,900 Mar 16, 2022 0.4300 0.4500 0.4000 0.4200 0.4200 3,014,600 Mar 15, 2022 0.4400 0.4400 0.4100 0.4400 0.4400 2,112,800 Mar 14, 2022 0.4600 0.5000 0.4300 0.4400 0.4400 4,611,500 Mar 11, 2022 0.3900 0.4900 0.3800 0.4100 0.4100 5,802,300 Mar 10, 2022 0.3900 0.4200 0.3800 0.4000 0.4000 2,976,200 Mar 09, 2022 0.4000 0.4200 0.3800 0.3800 0.3800 2,796,100 Mar 08, 2022 0.3800 0.3900 0.3400 0.3800 0.3800 4,408,400 Mar 07, 2022 0.3900 0.4200 0.3800 0.3900 0.3900 4,876,700 Mar 04, 2022 0.4600 0.5000 0.3800 0.4200 0.4200 6,124,500 Mar 03, 2022 0.5000 0.5500 0.4400 0.4500 0.4500 9,200,300 Mar 02, 2022 0.4700 0.5900 0.4400 0.4900 0.4900 12,969,800 Mar 01, 2022 0.4400 0.7500 0.4100 0.5000 0.5000 85,470,400 Feb 28, 2022 0.4000 0.4800 0.4000 0.4300 0.4300 10,001,400 Feb 25, 2022 0.3800 0.5400 0.3700 0.4200 0.4200 37,306,600 Feb 24, 2022 0.3300 0.3600 0.3000 0.3500 0.3500 3,792,400 Feb 23, 2022 0.3500 0.3700 0.3400 0.3400 0.3400 2,301,200 Feb 22, 2022 0.3700 0.3800 0.3300 0.3600 0.3600 3,656,000 Feb 18, 2022 0.4100 0.4400 0.3800 0.3800 0.3800 4,322,300 Feb 17, 2022 0.4200 0.4400 0.3900 0.3900 0.3900 4,300,300 Feb 16, 2022 0.4000 0.4300 0.3900 0.4200 0.4200 4,666,100 Feb 15, 2022 0.3800 0.4100 0.3700 0.4000 0.4000 5,246,500 Feb 14, 2022 0.4000 0.4000 0.3600 0.3800 0.3800 3,511,700 Feb 11, 2022 0.4300 0.4400 0.3800 0.4000 0.4000 8,273,300 Feb 10, 2022 0.3800 0.4200 0.3800 0.4000 0.4000 7,406,900 Feb 09, 2022 0.3900 0.4000 0.3600 0.3900 0.3900 8,213,200 Feb 08, 2022 0.3600 0.4000 0.3500 0.3700 0.3700 10,978,900 Feb 07, 2022 0.3800 0.3800 0.3500 0.3600 0.3600 9,362,500 Feb 04, 2022 0.3300 0.3700 0.3300 0.3600 0.3600 32,068,000 Feb 03, 2022 0.8200 0.8400 0.7000 0.7000 0.7000 1,559,600 Feb 02, 2022 0.9200 0.9400 0.8700 0.8700 0.8700 405,600 Feb 01, 2022 0.9500 1.0400 0.8600 0.9200 0.9200 416,400 Jan 31, 2022 1.0000 1.0000 0.9400 0.9500 0.9500 231,600
RMED Stock Statics Stock Price History Balance Sheet Valuation Measures Market Cap (intraday) 11.48M Enterprise Value -1.30M Trailing P/E N/A Forward P/E N/A PEG Ratio (5 yr expected) N/A Price/Sales (ttm) 100.18 Price/Book (mrq) 0.84 Enterprise Value/Revenue -59.23 Enterprise Value/EBITDA 0.04
Trading Information Stock Price History Beta (5Y Monthly) 1.65 52-Week Change -92.14% S&P500 52-Week Change 14.40% 52 Week High 9.8200 52 Week Low 0.3000 50-Day Moving Average 0.6076 200-Day Moving Average 2.4347
Share Statistics Avg Vol (3 month) 5.52M Avg Vol (10 day) 4.61M Shares Outstanding 26.33M Implied Shares Outstanding N/A Float 6.53M % Held by Insiders 1.76% % Held by Institutions 2.62% Shares Short (Mar 14, 2022) 3.43M Short Ratio (Mar 14, 2022) 0.32 Short % of Float (Mar 14, 2022) 13.19% Short % of Shares Outstanding (Mar 14, 2022) 13.04% Shares Short (prior month Feb 14, 2022) 1.7M
Dividends & Splits Forward Annual Dividend Rate N/A Forward Annual Dividend Yield N/A Trailing Annual Dividend Rate 0.00 Trailing Annual Dividend Yield 0.00% 5 Year Average Dividend Yield N/A Payout Ratio 0.00% Dividend Date Nov 16, 2020 Ex-Dividend Date N/A Last Split Factor 1:25 Last Split Date Nov 16, 2020
Financial Highlights Fiscal Year Fiscal Year Ends Dec 30, 2021 Most Recent Quarter (mrq) Dec 30, 2021
Profitability Profit Margin 0.00% Operating Margin (ttm) -133,027.27%
Management Effectiveness Return on Assets (ttm) -67.15% Return on Equity (ttm) -156.58%
Income Statement Revenue (ttm) 22k Revenue Per Share (ttm) 0.00 Quarterly Revenue Growth (yoy) -99.60% Gross Profit (ttm) -1.54M EBITDA -28M Net Income Avi to Common (ttm) -27.26M Diluted EPS (ttm) -4.9590 Quarterly Earnings Growth (yoy) N/A
Balance Sheet Total Cash (mrq) 15.04M Total Cash Per Share (mrq) 2.23 Total Debt (mrq) 2.26M Total Debt/Equity (mrq) 16.56 Current Ratio (mrq) 3.17 Book Value Per Share (mrq) 2.03
Cash Flow Statement Operating Cash Flow (ttm) N/A Levered Free Cash Flow (ttm) N/A
Follow us or bookmark us for more Bollywood news box office collection report celebrities trailers and promos
Join us on Facebook :
Join us on Twitter :
